Skip to content
MedsAcross

Molecule

Trisodium

Also known as trisodium citrate dihydrate
Available on request
Presentations
7
Brands
5
Manufacturers
5
Available from stock
0

Trisodium is an anti-coagulant. It is available as injection and solution for intravenous and extracorporeal use. MedsAcross supplies Trisodium for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Anti-coagulant, Calculi Dissolution Agent, Acidifying Activity, Calcium Chelating Activity, Decreased Coagulation Factor Activity
US FDA first approval
Not recorded
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intravenous, Extracorporeal
Dosage forms
Injection, Solution
Identifiers
UNII B22547B95KRxCUI 221163CAS 6132-04-3DrugBank DB09159Q22075862

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures.

Source: US FDA prescribing information

How it works

SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP acts as an extracorporeal anticoagulant by binding the free calcium in the blood. Calcium is a necessary co-factor to several steps in the clotting cascade. The following ingredients are key components of the solution: Citric acid for pH regulation Sodium Citrate anticoagulant This solution has no pharmacological effect.

Source: US FDA prescribing information

Dosing overview

SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP is added to tubing sets during apheresis procedures. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP may only be used with apheresis devices. For instructions on the use of the solution see the apheresis device operator's manual. Follow the directions for connecting the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP bag to the apheresis system.

Source: US FDA prescribing information

Warnings and precautions

Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the anticoagulant (AC) line on the system tubing set. Use aseptic technique throughout all procedures to ensure donor safety and quality. Single-use container. Do not reuse. Discard any unused or partially used product. Rx only. Single-use container, do not reuse. Rx only

Source: US FDA prescribing information

Side effects

Citrate reactions or toxicity may occur with the infusion of blood products to patients and return of blood containing citrate anticoagulant to donors. The recipient of the blood containing citrate should be monitored for the signs and symptoms of citrate toxicity. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Citrate toxicity may occur more frequently in patients who are hypothermic, have impaired liver or renal function, or have low calcium levels because of an underlying disease. Citrate reactions or toxicity may occur with the infusion and return of blood containing citrate anticoagulant.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

7 presentations of Trisodium, sorted by availability.

MedicineManufacturerRegisterAvailability
Anticoagulant Sodium Citrate 40 mg/mL solutionExtracorporealLaboratorios GrifolsUS FDAAvailable on request
Sodium Citrate Blood-Pack Units, (PL 146 Plastic) 10 g/250 mL injectionIntravenousFenwalUS FDAAvailable on request
triCitrasol 14 g/30 mL solutionExtracorporealCitra LabsUS FDAAvailable on request
Anticoagulant Sodium Citrate 40 mg/mL solutionExtracorporealBaxter HealthcareUS FDAAvailable on request
Sodium Citrate 4% w/v Anticoagulant 10 g/250 mL injectionIntravenousTerumo BCTUS FDAAvailable on request
Sodium Citrate Blood-Pack Units, (PL 146 Plastic) 20 g/500 mL injectionIntravenousFenwalUS FDAAvailable on request
Sodium Citrate w/v Anticoagulant 10 g/250 mL injectionIntravenousTerumo BCTUS FDAAvailable on request

Brands by market

5 brand names across 1 markets.

Brand names by country

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDANot recorded—
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Trisodium available for export from India?

Yes, on request. MedsAcross lists 7 presentations of Trisodium and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Trisodium have?

The catalogue lists 5 brand names for Trisodium, including Anticoagulant Sodium Citrate, Sodium Citrate 4% w/v Anticoagulant, Sodium Citrate Blood-Pack Units, (PL 146 Plastic), Sodium Citrate w/v Anticoagulant, triCitrasol.

Does Trisodium need cold chain shipping?

No listed presentation of Trisodium is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Sodium Citrate w/v Anticoagulant prescribing information (Terumo BCT). U.S. National Library of Medicine, DailyMed. Retrieved 24 January 2025

Request Trisodium for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.